Reuters -- Delcath Systems Inc said an independent group of experts recommended a late-stage trial of its cancer treatment to continue patient enrollment after reviewing clinical data on the already enrolled patients.
Reuters -- Delcath Systems Inc said an independent group of experts recommended a late-stage trial of its cancer treatment to continue patient enrollment after reviewing clinical data on the already enrolled patients.
